As of 2025-05-23, the Relative Valuation of AxoGen Inc (AXGN) is (4.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.94 USD, the upside of AxoGen Inc based on Relative Valuation is -141.8%.
The range of the Relative Valuation is (4.36) - (5.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 33.8x | 24.8x |
| Forward P/E multiples | 27.0x - 32.6x | 31.9x |
| Fair Price | (4.36) - (5.27) | (4.58) |
| Upside | -139.8% - -148.1% | -141.8% |
| Date | P/E |
| 2025-05-13 | -67.35 |
| 2025-05-12 | -70.51 |
| 2025-05-09 | -70.35 |
| 2025-05-08 | -77.93 |
| 2025-05-07 | -101.46 |
| 2025-05-06 | -101.58 |
| 2025-05-05 | -103.68 |
| 2025-05-02 | -106.04 |
| 2025-05-01 | -102.01 |
| 2025-04-30 | -100.71 |
| 2025-04-29 | -102.20 |
| 2025-04-28 | -100.16 |
| 2025-04-25 | -101.52 |
| 2025-04-24 | -100.03 |
| 2025-04-23 | -96.69 |
| 2025-04-22 | -95.51 |
| 2025-04-21 | -93.97 |
| 2025-04-17 | -96.38 |
| 2025-04-16 | -96.44 |
| 2025-04-15 | -96.88 |
| 2025-04-14 | -99.41 |
| 2025-04-11 | -98.36 |
| 2025-04-10 | -97.80 |
| 2025-04-09 | -103.75 |
| 2025-04-08 | -98.49 |
| 2025-04-07 | -102.88 |
| 2025-04-04 | -100.40 |
| 2025-04-03 | -105.48 |
| 2025-04-02 | -109.50 |
| 2025-04-01 | -110.25 |
| 2025-03-31 | -114.52 |
| 2025-03-28 | -113.65 |
| 2025-03-27 | -117.55 |
| 2025-03-26 | -116.37 |
| 2025-03-25 | -117.55 |
| 2025-03-24 | -112.35 |
| 2025-03-21 | -109.69 |
| 2025-03-20 | -111.67 |
| 2025-03-19 | -110.80 |
| 2025-03-18 | -109.13 |
| 2025-03-17 | -113.16 |
| 2025-03-14 | -106.78 |
| 2025-03-13 | -106.22 |
| 2025-03-12 | -108.02 |
| 2025-03-11 | -107.83 |
| 2025-03-10 | -106.28 |
| 2025-03-07 | -109.75 |
| 2025-03-06 | -110.00 |
| 2025-03-05 | -112.72 |
| 2025-03-04 | -115.26 |